NDC codes

FDA NDC Directory
Product NDC (as listed)69367-419Labeler and product segments. Claims need a package NDC.
Product NDC at billing width69367-0419Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
69367-419-016936704190169367041901100 TABLET in 1 BOTTLE (69367-419-01)Marketed from Nov 25, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Carisoprodol
Generic name (nonproprietary)
carisoprodol
Active ingredients
Carisoprodol — 250 mg/1
Dosage form
Tablet
Route
Oral
Labeler
Westminster Pharmaceuticals, LLCNDC labeler code 69367
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 207237
Marketing start
Listing expires
DEA schedule
CIV
Other FDA classes
Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers
Product ID 69367-419_829cccf4-83d3-48d3-93a3-4e1ec01664baSPL ID 829cccf4-83d3-48d3-93a3-4e1ec01664baSPL set ID bfb31551-8c57-4360-be3a-f6fbe84a891eRxCUI 197446, 730794UNII 21925K482HUPC 0369367419017, 0369367420013
Pharmacologic class
Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469367041901 followed by a unit qualifier and the quantity

Package 69367-0419-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Carisoprodol tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol tablets should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration [ see Dosage and Administration (2) ]. Carisoprodol tablet is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. ( 1 ) Limitation of Use Should only be used for acute treatment periods up to two or three weeks (…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69367-419

What is NDC 69367-419?
69367-419 is the product NDC for Carisoprodol, Carisoprodol 250 mg/1 tablet, listed with the FDA by Westminster Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Carisoprodol.
What is the active ingredient?
Carisoprodol.
Who is the labeler?
Westminster Pharmaceuticals, LLC, NDC labeler code 69367. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carisoprodol?
46 other product NDCs are listed under this name. See all Carisoprodol NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carisoprodol NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
CarisoprodolCarisoprodol 350 mg/1TabletOralSt. Mary's Medical Park Pharmacy60760-39760760-0397-90
CarisoprodolCarisoprodol 350 mg/1TabletOralWestminster Pharmaceuticals, LLC69367-42069367-0420-0169367-0420-05
CarisoprodolCarisoprodol 350 mg/1TabletOralNorthwind Health Company, LLC82868-06282868-0062-30
carisoprodolCarisoprodol 350 mg/1TabletOralREMEDYREPACK INC.70518-379270518-3792-00
CarisoprodolCarisoprodol 350 mg/1TabletOralAdvanced Rx Pharmacy of Tennessee, LLC80425-029180425-0291-0180425-0291-0280425-0291-03
CarisoprodolCarisoprodol 350 mg/1TabletOralDirect_Rx72189-38672189-0386-3072189-0386-7272189-0386-90
CarisoprodolCarisoprodol 350 mg/1TabletOralDirectrx72189-31072189-0310-3072189-0310-6072189-0310-72+1 more
CarisoprodolCarisoprodol 350 mg/1TabletOralREMEDYREPACK INC.70518-280070518-2800-00
CarisoprodolCarisoprodol 350 mg/1TabletOralMedsource Pharmaceuticals45865-23345865-0233-3045865-0233-60
CarisoprodolCarisoprodol 350 mg/1TabletOralA-S Medication Solutions50090-595350090-5953-05

All 47 Carisoprodol NDCs

Other NDCs under ANDA 207237

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207237
ProductStrengthForm · routeLabelerProduct NDC
CarisoprodolCarisoprodol 250 mg/1TabletOralBryant Ranch Prepack63629-9144
CarisoprodolCarisoprodol 350 mg/1TabletOralWestminster Pharmaceuticals, LLC69367-420
CarisoprodolCarisoprodol 250 mg/1TabletOralBryant Ranch Prepack71335-2708

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in